Kingsview Wealth Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-30,572
Closed -$1.13M – 938
2023
Q2
$1.13M Buy
+30,572
New +$933K 0.04% 372
2021
Q2
– Sell
-37,768
Closed -$1.06M – 923
2021
Q1
$1.06M Buy
+37,768
New +$1M 0.06% 318

Other funds holding CC

Kingsview Wealth Management's CC Position: Q3 2023 in Review

Kingsview Wealth Management sold out of Chemours (CC) in Q3 2023, closing a stake of 30,572 shares — an estimated $1.13M sold.

Kingsview Wealth Management first reported a position in CC in Q1 2021 and held it in 2 quarters. The position peaked at $1.13M in Q2 2023. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • Kingsview Wealth Management reported no remaining Chemours position as of Q3 2023 after selling out during the quarter.
  • Kingsview Wealth Management sold 30,572 Chemours shares in Q3 2023, an estimated $1.13M.
  • Kingsview Wealth Management first reported a position in Chemours in Q1 2021 and held it in 2 quarters.
  • Kingsview Wealth Management's Chemours position peaked at $1.13M in Q2 2023.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Kingsview Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.